{"nct_id":"NCT03033511","title":"A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)","status":"TERMINATED","status_verified_date":"2021-07","start_date":"2017-02-07","start_date_type":"ACTUAL","primary_completion_date":"2019-11-20","primary_completion_date_type":"ACTUAL","completion_date":"2019-11-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}